AIM ImmunoTech Inc. Total Revenue

• AIM ImmunoTech Inc. showed an increase of +0.0% in Total Revenue from 2025 to 2025.
• This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2009 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2012: $53.0 thousand | Q1 2013: $42.0 thousand | Q2 2013: $36.0 thousand | Q3 2013: $36.0 thousand | Q4 2013: $36.0 thousand | Q1 2014: $76.0 thousand | Q2 2014: $36.0 thousand | Q3 2014: $45.0 thousand | Q1 2015: $36.0 thousand | Q2 2015: $47.0 thousand | Q3 2015: $23.0 thousand | Q2 2017: $213.0 thousand | Q3 2017: $90.0 thousand | Q1 2018: $56.0 thousand | Q2 2018: $33.0 thousand | Q2 2018: $33.0 thousand | Q3 2018: $38.0 thousand | Q3 2018: $38.0 thousand | Q2 2019: $29.0 thousand | Q3 2019: $61.0 thousand | Q1 2020: $45.0 thousand | Q2 2020: $40.0 thousand | Q3 2020: $36.0 thousand | Q1 2021: $28.0 thousand | Q2 2021: $23.0 thousand | Q3 2021: $33.0 thousand | Q1 2022: $33.0 thousand | Q1 2022: $33.0 thousand | Q2 2022: $30.0 thousand | Q2 2022: $30.0 thousand | Q3 2022: $21.0 thousand | Q3 2022: $21.0 thousand | Q1 2023: $49.0 thousand | Q1 2023: $49.0 thousand | Q2 2023: $42.0 thousand | Q2 2023: $42.0 thousand | Q3 2023: $46.0 thousand | Q3 2023: $46.0 thousand | Q1 2024: $40.0 thousand | Q1 2024: $40.0 thousand | Q2 2024: $50.0 thousand | Q2 2024: $50.0 thousand | Q3 2024: $35.0 thousand | Q3 2024: $35.0 thousand | Q1 2025: $16.0 thousand | Q1 2025: $16.0 thousand | Q2 2025: $25.0 thousand | Q2 2025: $25.0 thousand | Q3 2025: $26.0 thousand | Q3 2025: $26.0 thousand.
• Over the full 20 years of available data (2009 to 2025), AIM ImmunoTech Inc.'s Total Revenue has declined by 20.7%.
• Historical annual values: Fiscal year 2025: $88.0 thousand | Fiscal year 2025: $88.0 thousand | Fiscal year 2024: $170.0 thousand | Fiscal year 2024: $170.0 thousand | Fiscal year 2023: $202.0 thousand | Fiscal year 2023: $202.0 thousand | Fiscal year 2022: $141.0 thousand | Fiscal year 2022: $141.0 thousand | Fiscal year 2021: $135.0 thousand | Fiscal year 2020: $163.0 thousand | Fiscal year 2019: $140.0 thousand | Fiscal year 2018: $367.0 thousand | Fiscal year 2018: $367.0 thousand | Fiscal year 2017: $437.0 thousand | Fiscal year 2014: $197.0 thousand | Fiscal year 2013: $150.0 thousand | Fiscal year 2012: $213.0 thousand | Fiscal year 2011: $161.0 thousand | Fiscal year 2010: $135.0 thousand | Fiscal year 2009: $111.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026